Cargando…
An adapted consensus protein design strategy for identifying globally optimal biotherapeutics
Biotherapeutic optimization, whether to improve general properties or to engineer specific attributes, is a time-consuming process with uncertain outcomes. Conversely, Consensus Protein Design has been shown to be a viable approach to enhance protein stability while retaining function. In adapting t...
Autores principales: | Liu, Yanyun, Tsang, Kenny, Mays, Michelle, Hansen, Gale, Chiecko, Jeffrey, Crames, Maureen, Wei, Yangjie, Zhou, Weijie, Fredrick, Chase, Hu, James, Liu, Dongmei, Gebhard, Douglas, Huang, Zhong-Fu, Datar, Akshita, Kronkaitis, Anthony, Gueneva-Boucheva, Kristina, Seeliger, Daniel, Han, Fei, Sen, Saurabh, Kasturirangan, Srinath, Scheer, Justin M., Nixon, Andrew E., Panavas, Tadas, Marlow, Michael S., Kumar, Sandeep |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9135432/ https://www.ncbi.nlm.nih.gov/pubmed/35613320 http://dx.doi.org/10.1080/19420862.2022.2073632 |
Ejemplares similares
-
Embedding Dynamics in Intrinsic Physicochemical Profiles
of Market-Stage Antibody-Based Biotherapeutics
por: Licari, Giuseppe, et al.
Publicado: (2022) -
Intrinsic physicochemical profile of marketed antibody-based biotherapeutics
por: Ahmed, Lucky, et al.
Publicado: (2021) -
Patient-derived lymphoblastoid cell lines harboring mitochondrial DNA mutations as tool for small molecule drug discovery
por: Chin, Randall Marcelo, et al.
Publicado: (2018) -
How can we discover developable antibody-based biotherapeutics?
por: Bauer, Joschka, et al.
Publicado: (2023) -
Advances in the Development of Biotherapeutics
por: Oliveira, Pedro H., et al.
Publicado: (2015)